« Back
Home /
Bcl-2 Inhibitor 5mg

Bcl-2 Inhibitor 5mg

Item no.	A13580-5
Manufacturer	Adooq
CASRN	383860-03-5
Amount	5 mg
Quantity options	10 mg 25 mg 5 mg
Category	Oncology By Cell Type Blastoma Carcinoma Hematology Leukemia Lymphoma Myeloma Cell Biology Cell Status Apoptosis Autophagy Inhibitors & Compound Libraries Small Molecules By Organ Colorectal Cancer Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Purity	>98%
Smiles	COC1=CC(=C(C=C1)N=O)CCC2=C(C=CC(=C2)OC)N=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	TW-37
Similar products	383860-03-5
Available
Storage Conditions	2 years at -20C
Molecular Weight	300, 3
Chemical Name	N-[4-[[2-(1, 1-DIMETHYLETHYL)PHENYL]SULFONYL]PHENYL]-2, 3, 4-TRIHYDROXY-5-[[2-(1-METHYLETHYL)PHENYL]METHYL]BENZAMIDE
Description	Bcl-2 Inhibitor contains a mixture of two tautomers. A potent, cell-permeable, Bcl-2 inhibitor competes with Bak BH3 peptide for binding to Bcl-2 and Bcl-x in vitro (IC50 =10 uM and 7 uM, respectively).
Solubilty	DMSO

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

A13580-5-datasheet.pdf

A13580-5-safety-datasheet.pdf